Global In Vitro Diagnostics (ivd) Market
![](https://www.blueweaveconsulting.com/assets/front/images/cover-new-3.png)
Global In Vitro Diagnostics (IVD) Market- By Type (Product [Reagents & Kits, Instruments], Service [Software, Testing Services]), By Technology (Clinical Chemistry, Immunoassay/ Immunochemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis), By Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/ Pharmacogenomics), By End-User (Hospitals, Point-Of-Care Testing, Laboratories, Academic Institutes), By Region (North America, Europe, the Asia-Pacific, Latin America and the Middle East and Africa); Trend Analysis, Competitive Market Share & Forecast, 2017-2027
- Published Date: March 2021
- Report ID: BWC20296
- Available Format: PDF
- Page: 178
Report Overview
Global In-Vitro Diagnostics(IVD) market reached USD 82.3 billion in 2020 and is further projected to reach USD 102.4 billion by 2027, growing at a CAGR of 3.2% during 2021-2027 (forecast period).Global In-Vitro Diagnostics(IVD) Market- Industry Trends & Forecast Report 2027
Global In-Vitro Diagnostics(IVD) market reached USD 82.3 billion in 2020 and is further projected to reach USD 102.4 billion by 2027, growing at a CAGR of 3.2% during 2021-2027 (forecast period). The growth of the global IVD market has been positively impacted by the growing demand for POC (Point-of-Care) IVD devices. The newly launched IVD instruments/devices are efficient and easy to use, which has increased their adoption among healthcare professionals. Also, the demand for some over-the-counter diagnostics devices such as glucose monitoring kits available in the market to minimize hospital visits is highly preferred by the elderly. Since individuals prefer easy diagnostics tests that can be done in-home healthcare settings, the demand for such items went up during the COVID-19 pandemic. These factors, combined with the rising prevalence of chronic diseases, such as cancer and diabetes, increasing awareness about disease diagnosis, and growing levels of disposable income are likely to drive the growth of the industry.
Source: BlueWeave Consulting
Global IVD Market Forecast and Trends
Growth Drivers
Growing Prevalence of Chronic and Infectious Diseases in Geriatric Population
The growth of the IVD market would be positively influenced by the growing geriatric population in developed as well as emerging regions. With the exponential growth of the geriatric population globally, it is predicted that the incidence of age-related diseases will increase significantly. The number of older people living in the US in 2019 was 54 million according to the OECD. Huge and increasing geriatric populations also exist in other developed economies around the world. For example, in Japan, followed by Germany, the ratio of the elderly population to the active population is the largest. Japan's total population is about 126 million, with older people accounting for more than 28% of the population.
The geriatric population in Germany accounts for about 21% of the population of the country. The risk of contracting diseases rises proportionately with age. For example, approximately 80% of the elderly population in the US suffers from one chronic illness, according to the Centers for Disease Control and Prevention. And by 2030, 60% of people aged 65 years or older are expected to be living with more than one chronic condition, according to American Medical Association. In the age group of 60 years and beyond, pneumonia is one of the deadly infectious diseases affecting the elderly population.
Technological Advancements in IVD Tools
Demand for point-of-care (POC) devices is likely to increase with the advent of new technologies, such as biochips and nano-biotechnology, and the miniaturization of microfluidic instruments. These advanced methods have allowed easy access to Diagnostics point-of-care testing and deliver quick and valid test results, fueling the market for IVD tools. Subsequently, these factors are anticipated to drive market growth during the forecast period. For example, in June 2019, Abbott released the first rapid point-of-care test for the diagnosis of diabetes among the general population, the Afinion HbA1c Dx assay.
The growth of the market is likely to be driven by increased investment by key market players in the production of technologically advanced and rapid testing instruments. Recently, the market is driven by rapid and precise tests for the diagnosis of infectious diseases and other chronic diseases. Sekisui Diagnostics announced the introduction of the Silaris Influenza A& B Test for point-of-care (POC) for infectious disease diagnosis in March 2018. Such product launches would move the choice of patients from standard Diagnostics instruments to advanced IVD services.
Restraints
Unfavorable Reimbursement Scenario
A major factor restraining the growth of the IVD market is inadequate reimbursement. In the United States, a few years ago, Medicare updated its reimbursement mechanism for certain IVD studies, including molecular tests. Some of these tests for molecular pathology do not have codes for their own Healthcare Standard Procedure Coding System (HCPCS) and are billed using unlisted codes instead. In such cases, a reimbursement amount for their local jurisdictions is set up by Medicare Administrative Contractors (MACs). Approximately 75% of studies reported decreases in reimbursement rates as of January 2017, according to CMS. Some of those studies include genetic tests, five to 50 gene-targeted NGS review tables, and cancer tests. It is anticipated that these advances would have a negative effect on the US market for molecular and genetic testing, which would impede the growth of the IVD market.
Impact of COVID-19 on Global IVD Market
Major Tier I and II suppliers, such as Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers, compose the IVD industry. Throughout the Asia-Pacific, Europe, North America, South America, and RoW, these suppliers have their manufacturing facilities spread across different countries. COVID-19 has also affected their companies. In order to survive market competition, companies began to implement rapid Diagnostics tests. The importance of these things has increased since the COVID-19 pandemic, as people prefer basic screening tests that can be carried out in-home health care settings. The positive influence of COVID-19 on the market for IVD products may be attributed to the high growth rate of kit and reagent products.
The advent of the pandemic has increased the need for reagents and kits that provide rapid diagnosis and help combat the harmful consequences of coronavirus. It is expected that the outbreak of COVID-19 would have a positive effect on the market being examined, as IVD requires testing of different biological samples. The diagnosis of infectious diseases, such as COVID-19, is supposed to support this growth factor. In controlling the COVID-19 pandemic, testing remains a critical step. As the number of COVID-19 cases are rising worldwide, the possibilities of enabling private laboratories to scale up research are being discussed by governments of different countries. The rapid launch of diagnostics kits by key players for the diagnosis of COVID-19 is also driving the market during the pandemic.
Global IVD Market- By Type
Based on type, the market has been segmented into- products (reagents & kits, instruments), and services (software, testing services). It is anticipated that the reagents segment would dominate the market during the forecast period. The growth of this segment can be attributed to the growing demand for rapid, accurate, and sensitive devices. Additionally, their large use in in-vitro diagnostics research, increased demand for self-testing and point-of-care products, and an increase in the number of reagent-related R&D initiatives are expected to support market development. Equipment and machines are referred to as analytical tools that simplify the diagnostics process and bring reagents and samples together. Commercial kits and robots are used for identifying and measuring infectious microorganisms, blood antigens, and viral load in polymerase chain reaction (PCR) laboratories.
Global IVD Market- By Application
Based on applications, the market is segmented into- oncology, infectious diseases, diabetes, cardiology, nephrology, autoimmune diseases, and drug testing/ pharmacogenomics. It is anticipated that the infectious disease segment would dominate the market during the forecast period. This is due to the growing prevalence of infectious diseases such as SARS-CoV-2, HIV, AIDS, tuberculosis, and pneumonia. Additionally, the segment is expected to be powered by a rise in the production of infectious disease detection assays by market players for IVD. In December 2018, for example, Siemens Healthineers received U.S.(Food and Drug Administration) FDA premarket approval for its 12 new assays for viral hepatitis and other diseases.
Source: BlueWeave Consulting
Global IVD Market- By Region
Based on region, the market has been segmented into North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa. It is anticipated that North America will witness the largest revenue in the market due to the presence of numerous local market players in the region. Additionally, the growing demand for improved diagnostics devices are being propelled by the increasing prevalence of diseases and increased customer awareness. The market is projected to exhibit the highest growth over the forecast period in the Asia-Pacific, with a CAGR of 4.3%. because of the existence of emerging economies. Additionally, increased healthcare awareness and the growing demand for early diagnosis of patients in the area, along with a high prevalence of chronic diseases are likely to fuel the market.
Competitive Landscape
The presence of leading players in this market space is diminishing the opportunities for new entrants to the market as it is difficult to match the high capital requirements. Some of the key players include Abbott, Danaher, Siemens Healthineers AG, Roche Diagnostics, Sysmex Corporation, QIAGEN, Quidel Corporation, Quest Diagnostics, Agilent Technologies, and Bio-Rad Laboratories. The IVD market is price-sensitive, so players are competing intensively in terms of producing cost-effective and productive goods. In order to improve their production capability, product portfolio, and provide competitive differentiation, companies are increasingly participating in acquisitions, alliances, and mergers. Furthermore, companies are focused on securing consumer acceptance for novel drugs for the diagnosis of various infectious diseases.
Recent Developments
- On 11th November 2020, Sysmex obtained marketing and manufacturing approval for a SARS-CoV-2 Antigen Detection Reagent. The launch of new diagnosis/treatment procedures for COVID-19 had a positive impact on the growth of the company.
- In September 2020, Roche Diagnostics released an antibody test for SARS-CoV-2. The launch of innovative products is driving the company’s growth significantly. Additionally, the introduction of antigen tests amid the pandemic favored the growth of the business.
Scope of Report
Attribute | Details |
Years considered | Historical data- 2017-2020 |
Base Year- 2021 | |
Forecast- 2021-2027 | |
Facts covered | Revenue in USD billion |
Market coverage | US, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, Australia, Argentina, UAE, South Africa, Saudi Arabia, Turkey, Egypt, and others |
Product/ Service segmentation | By type, By Application, By Technology, By end-user |
Key Players | Abbott, Danaher, Siemens Healthineers AG, Roche Diagnostics, Sysmex Corporation, QIAGEN, Quidel Corporation, Quest Diagnostics, Agilent Technologies, and Bio- Rad Laboratories |
Scope of Report
By Type
- Product
- Reagents & Kits
- Instruments
- Service
- Software
- Testing Services
- By Technology
- Clinical Chemistry
- Immunoassay/ Immunochemistry
- Molecular Diagnostics
- Hematology
- Microbiology
- Coagulation & Hemostasis
- Urinalysis
- By Application
- Oncology
- Infectious Disease
- Diabetes
- Cardiology
- Nephrology
- Autoimmune disease
- Drug testing/ pharmacogenomics
- By End-User
- Hospitals
- Point of Care Testing
- Laboratories
- Academic Institutes
- By Region
- North America
- Europe
- The Asia-Pacific
- Latin America
- The Middle East and Africa
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global In Vitro DiagnosticsMarket Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Recent Development
4.4. Porter’s Five Forces Analysis
4.4.1. Bargaining Application of Suppliers
4.4.2. Bargaining Application of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Intensity of Rivalry
5. Global In Vitro DiagnosticsMarket Overview
5.1. Market Size & Forecast by Value, 2017-2027
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Type
5.2.1.1. Product
5.2.1.1.1. Reagents & Kits
5.2.1.1.2. Instruments
5.2.1.2. Service
5.2.1.2.1. Software
5.2.1.2.2. Testing Services
5.2.2. By Technology
5.2.2.1. Clinical chemistry
5.2.2.2. Immunoassay? Immunochemistry
5.2.2.3. Molecular Diagnostics
5.2.2.4. Hematology
5.2.2.5. Microbiology
5.2.2.6. Coagulation & Hemostasis
5.2.2.7. Urinalysis
5.2.3. By Application
5.2.3.1. Oncology
5.2.3.2. Infectious disease
5.2.3.3. Diabetes
5.2.3.4. Cardiology
5.2.3.5. Nephrology
5.2.3.6. Autoimmune disease
5.2.3.7. Drug testing? pharmacogenomics
5.2.4. By End User
5.2.4.1. Hospitals
5.2.4.2. Point of Care Testing
5.2.4.3. Laboratories
5.2.4.4. Academic Institutes
5.2.5. By Region
5.2.5.1. North America
5.2.5.2. Europe
5.2.5.3. Asia Pacific
5.2.5.4. Latin America
5.2.5.5. Middle East and Africa
6. North America In Vitro DiagnosticsMarket
6.1. Market Size & Forecast by Value, 2017-2027
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.2.5.1. United States
6.2.5.2. Canada
7. Europe In Vitro DiagnosticsMarket
7.1. Market Size & Forecast by Value, 2017-2027
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.2.5.1. Germany
7.2.5.2. United Kingdom
7.2.5.3. Italy
7.2.5.4. France
7.2.5.5. Spain
7.2.5.6. Rest of Europe
8. Asia Pacific In Vitro DiagnosticsMarket
8.1. Market Size & Forecast by Value, 2017-2027
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.2.5.1. China
8.2.5.2. India
8.2.5.3. Japan
8.2.5.4. Singapore
8.2.5.5. South Korea
8.2.5.6. Rest of Asia Pacific
9. Latin America In Vitro DiagnosticsMarket
9.1. Market Size & Forecast by Value, 2017-2027
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.2.5.1. Brazil
9.2.5.2. Mexico
9.2.5.3. Rest of Latin America
10. Middle East & Africa In Vitro DiagnosticsMarket
10.1. Market Size & Forecast by Value, 2017-2027
10.1.1. By Value (USD Million)
10.2.1. By Type
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.2.5.1. Saudi Arabia
10.2.5.2. GCC
10.2.5.3. UAE
10.2.5.4. South Africa
10.2.5.5. Rest of Middle East & Africa
11. Competitive Landscape
11.1. List of Key Players and Their Offerings
11.2. Market/Ranking Share Analysis
11.3. Competitive Benchmarking, By Operating Parameters
12. Impact of Covid-19 on In Vitro DiagnosticsMarket Industry
13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)**
13.1. Abbott
13.2. BD
13.3. Bio-Rad Laboratories
13.4. bioMerieux SA
13.5. Cephied
13.6. Grifols
13.7. Johnson & Johnson Services
13.8. Luminex
13.9. LivaNova
13.10. Ortho Clinical Diagnostics
13.11. Qiagen
13.12. F-Hoffmann-La-Roche
13.13. Siemens
13.14. Sysmex Corporation
13.15. Thermo Fisher Scientific
13.16. Others
*Financial details of unlisted companies will be available as per data available in final deliverable
**The segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable
List of Figures
Fig: Global In Vitro Diagnostics Segmentation
Fig: Global In Vitro Diagnostics Market Value Chain Analysis
Fig: Company Market Share Analysis, 2019
Fig: Global In Vitro Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Global In Vitro Diagnostics Market Share, By Type, By Value, 2017-2027
Fig: Global In Vitro Diagnostics Market Share, By Technology, By Value, 2017-2027
Fig: Global In Vitro Diagnostics Market Share, By Application, By Value, 2017-2027
Fig: Global In Vitro Diagnostics Market Share, By End User, By Value, 2017-2027
Fig: Global In Vitro Diagnostics Market Share, By Region, By Value, 2017-2027
Fig: North America In Vitro Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: North America In Vitro Diagnostics Market Share, By Type, By Value, 2017-2027
Fig: North America In Vitro Diagnostics Market Share, By Technology, By Value, 2017-2027
Fig: North America Gowns Market Share, By Application, By Value, 2017-2027
Fig: North America Gowns Market Share, By End User, By Value, 2017-2027
Fig: North America In Vitro Diagnostics Market Share, By Country, By Value, 2017-2027
Fig: Europe In Vitro Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Europe In Vitro Diagnostics Market Share, By Type, By Value, 2017-2027
Fig: Europe In Vitro Diagnostics Market Share, By Technology, By Value, 2017-2027
Fig: Europe In Vitro Diagnostics Market Share, By Application, By Value, 2017-2027
Fig: Europe Gowns Market Share, By End User, By Value, 2017-2027
Fig: Europe In Vitro Diagnostics Market Share, By Country, By Value, 2017-2027
Fig: Asia-Pacific In Vitro Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Asia-Pacific In Vitro Diagnostics Market Share, By Type, By Value, 2017-2027
Fig: Asia-Pacific In Vitro Diagnostics Market Share, By Technology, By Value, 2017-2027
Fig: Asia-Pacific In Vitro Diagnostics Market Share, By Application, By Value, 2017-2027
Fig: Asia-Pacific Gowns Market Share, By End User, By Value, 2017-2027
Fig: Asia-Pacific In Vitro Diagnostics Market Share, By Country, By Value, 2017-2027
Fig: Latin America In Vitro Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Latin America In Vitro Diagnostics Market Share, By Type, By Value, 2017-2027
Fig: Latin America In Vitro Diagnostics Market Share, By Technology, By Value, 2017-2027
Fig: Latin America In Vitro Diagnostics Market Share, By Application, By Value, 2017-2027
Fig: Latin America Gowns Market Share, By End User, By Value, 2017-2027
Fig: Latin America In Vitro Diagnostics Market Share, By Country, By Value, 2017-2027
Fig: Middle East & Africa In Vitro Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Middle East & Africa In Vitro Diagnostics Market Share, By Type, By Value, 2017-2027
Fig: Middle East & Africa In Vitro Diagnostics Market Share, By Technology, By Value, 2017-2027
Fig: Middle East & Africa In Vitro Diagnostics Market Share, By Application, By Value, 2017-2027
Fig: Middle East & Africa Gowns Market Share, By End-User, By Value, 2017-2027
Fig: Middle East & Africa In Vitro Diagnostics Market Share, By Country, By Value, 2017-2027
List of Tables
Table: Global In Vitro Diagnostics Market Size, By Type, By Value, 2017-2027
Table: Global In Vitro Diagnostics Market Size, By Technology, By Value, 2017-2027
Table: Global In Vitro Diagnostics Market Size, By Application, By Value, 2017-2027
Table: Global In Vitro Diagnostics Market Size, By Region, By Value, 2017-2027
Table: North America In Vitro Diagnostics Market Size, By Type, By Value, 2017-2027
Table: North America In Vitro Diagnostics Market Size, By Technology, By Value, 2017-2027
Table: North America In Vitro Diagnostics Market Size, By Application, By Value, 2017-2027
Table: North America In Vitro Diagnostics Market Size, By Country, By Value, 2017-2027
Table: Europe In Vitro Diagnostics Market Size, By Type, By Value, 2017-2027
Table: Europe In Vitro Diagnostics Market Size, By Technology, By Value, 2017-2027
Table: Europe In Vitro Diagnostics Market Size, By Application, By Value, 2017-2027
Table: Europe In Vitro Diagnostics Market Size, By Country, By Value, 2017-2027
Table: Asia-Pacific In Vitro Diagnostics Market Size, By Type, By Value, 2017-2027
Table: Asia-Pacific In Vitro Diagnostics Market Size, By Technology, By Value, 2017-2027
Table: Asia-Pacific In Vitro Diagnostics Market Size, By Application, By Value, 2017-2027
Table: Asia-Pacific In Vitro Diagnostics Market Size, By Country, By Value, 2017-2027
Table: Latin America In Vitro Diagnostics Market Size, By Type, By Value, 2017-2027
Table: Latin America In Vitro Diagnostics Market Size, By Technology, By Value, 2017-2027
Table: Latin America In Vitro Diagnostics Market Size, By Application, By Value, 2017-2027
Table: Latin America In Vitro Diagnostics Market Size, By Country, By Value, 2017-2027
Table: Middle East & Africa In Vitro Diagnostics Market Size, By Type, By Value, 2017-2027
Table: Middle East & Africa In Vitro Diagnostics Market Size, By Technology, By Value, 2017-2027
Table: Middle East & Africa In Vitro Diagnostics Market Size, By Application, By Value, 2017-2027
Table: Middle East & Africa In Vitro Diagnostics Market Size, By Country, By Value, 2017-2027
Table: Abbott Financial Analysis
Table: Danaher Financial Analysis
Table: Siemens Healthineers Financial Analysis
Table: Roche Diagnosticss Financial Analysis
Table: sysmex Corporation Financial Analysis
Table: QIAGEN Financial Analysis
Table: Bio Rad Laboratories Corporation Financial Analysis
Table: Quest Diagnosticss Financial Analysis
Table: Agilent Technologies Financial Analysis
Table: Bio Rad Laboratories Financial Analysis
Market Segmentation
Scope of Report
By Type
- Product
- Reagents & Kits
- Instruments
- Service
- Software
- Testing Services
- By Technology
- Clinical Chemistry
- Immunoassay/ Immunochemistry
- Molecular Diagnostics
- Hematology
- Microbiology
- Coagulation & Hemostasis
- Urinalysis
- By Application
- Oncology
- Infectious Disease
- Diabetes
- Cardiology
- Nephrology
- Autoimmune disease
- Drug testing/ pharmacogenomics
- By End-User
- Hospitals
- Point of Care Testing
- Laboratories
- Academic Institutes
- By Region
- North America
- Europe
- The Asia-Pacific
- Latin America
- The Middle East and Africa
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.